#VisualAbstract: Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 24, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 24, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 23, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 21, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 18, 2023
1. The progression-free survival in berzosertib with topotecan vs topotecan alone was not...
Read MoreNov 18, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 17, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 17, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 17, 2023
1. In this randomized controlled trial, in patients with treatment-resistant depression esketamine...
Read MoreNov 16, 2023
1. In this randomized controlled trial, in patients with heart failure with preserved ejection...
Read MoreNov 11, 2023
Bookmark Click here to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine,...
Read MoreNov 11, 2023
Bookmark 1. Median overall survival and progression-free survival were greater in the tebentafusp...
Read MoreNov 10, 2023
Bookmark Click here to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine,...
Read MoreNov 9, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreNov 8, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreNov 4, 2023
Bookmark Click here to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine,...
Read MoreNov 4, 2023
Bookmark 1. One-third of patients with a cancer signal were correctly diagnosed to have cancer. 2....
Read MoreNov 2, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreNov 1, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreNov 1, 2023
Bookmark Click to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine,...
Read More